Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Toxins01:36

Types of Toxins

1.7K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
1.7K
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

973
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
973
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Drug Regulation01:25

Drug Regulation

1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

821
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
821

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is Low Molecular Weight Polyethylene Glycol Used for Decontamination of Dermal Phenol Exposures?

Journal of occupational and environmental medicine·2025
Same author

Chemical Mixture Exposures and Their Effects on Sensitisation and Elicitation Responses: A Systematic Review.

Contact dermatitis·2025
Same author

QT interval prolongation in acute antipsychotic poisoning: systematic review and recommendations.

Clinical toxicology (Philadelphia, Pa.)·2025
Same author

Derivation and internal validation of a clinical diagnostic score for acute Chinese medicine poisoning involving aconite.

Clinical toxicology (Philadelphia, Pa.)·2025
Same author

Legislation and Current Practices Concerning Risk Assessment of Skin Sensitizers in the European Union: A Comparative and Survey Study.

Contact dermatitis·2025
Same author

The trajectory of serum salicylate concentrations after ingestion of medicinal oil containing methyl salicylate.

Clinical toxicology (Philadelphia, Pa.)·2024

Related Experiment Video

Updated: Jul 1, 2025

Assessment of Chemical Toxicity in Adult Drosophila Melanogaster
07:02

Assessment of Chemical Toxicity in Adult Drosophila Melanogaster

Published on: March 24, 2023

3.3K

The Clinical Toxicology Recommendations Collaborative: purpose, organization, and methodology.

Martin F Wilks1,2, Christopher Hoyte3,4, Kirk L Cumpston5

  • 1Swiss Centre for Applied Human Toxicology, University of Basel, Basel, Switzerland.

Clinical Toxicology (Philadelphia, Pa.)
|March 11, 2024
PubMed
Summary

The Clinical Toxicology Recommendations Collaborative (CTRC) develops evidence-based guidelines for poisoning management. This collaborative approach aims to improve patient care through unified, expert recommendations.

Keywords:
Clinical Toxicology Recommendations CollaborativeClinical recommendationsDelphi methodLikert scaleSystematic reviews

More Related Videos

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
11:38

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC

Published on: May 10, 2016

12.2K
Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
08:25

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Published on: June 5, 2020

6.7K

Related Experiment Videos

Last Updated: Jul 1, 2025

Assessment of Chemical Toxicity in Adult Drosophila Melanogaster
07:02

Assessment of Chemical Toxicity in Adult Drosophila Melanogaster

Published on: March 24, 2023

3.3K
High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
11:38

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC

Published on: May 10, 2016

12.2K
Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
08:25

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Published on: June 5, 2020

6.7K

Area of Science:

  • Clinical Toxicology
  • Medical Guidelines
  • Evidence-Based Practice

Background:

  • Scientific societies unify to address critical issues.
  • The Clinical Toxicology Recommendations Collaborative (CTRC) was established in 2016.
  • CTRC focuses on developing recommendations for unclear or controversial poisoning management.

Purpose of the Study:

  • To establish evidence- and consensus-based recommendations for patient poisoning management.
  • To create a unified stance on important issues in clinical toxicology.
  • To foster positive change for poisoned patients through international collaboration.

Main Methods:

  • Led by major clinical toxicology societies (AACT, APAMT, EAPCCT).
  • Utilizes Institute of Medicine standards and AGREE instrument.
  • Employs systematic reviews (GRADE methodology) and modified Delphi method (RAND/UCLA Appropriateness Method) for consensus.
  • Recommendations approved by unanimous consent, detailing levels of evidence and strength of recommendations.

Main Results:

  • The CTRC process involves systematic reviews and consensus-building.
  • Recommendations are derived from rigorous evidence assessment and expert voting.
  • Limitations include evidence quantity/quality and panel voting dynamics.

Conclusions:

  • CTRC employs a transparent, evidence- and consensus-based approach.
  • Aims to establish an international framework for clinical toxicology.
  • Enhances education and decision-making for improved patient outcomes in poisoning cases.